{"id":"W3167507808","doi":"10.1200/jco.2021.39.15_suppl.9546","title":"KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Discontinuation; Quality of life (healthcare); Cohort; Interim; Interim analysis; Pembrolizumab; Population; Clinical endpoint; Cancer; Clinical trial; Internal medicine; Gerontology; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008475738,0.0004122857,0.0005419484,0.0001786542,0.0001520059,0.0005443713,0.0003231797,0.000357813,0.004358116],"category_scores_gemma":[0.0005195732,0.0001385082,0.0006561952,0.0003909131,0.0001792539,0.0004622838,0.0004435733,0.0009304864,0.0004605348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005942627,"about_ca_system_score_gemma":0.0004916626,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005434489,"about_ca_topic_score_gemma":0.001070099,"domain_scores_codex":[0.9997419,0.00009959485,0.00002099048,0.00005092495,0.00003717232,0.00004950076],"domain_scores_gemma":[0.9997626,0.00002672956,0.00009520295,0.00001335172,0.00001674634,0.00008532098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4667346,0.02260607,0.08878624,0.001943923,0.002067468,0.0003391887,0.0002660206,0.005053529,0.0359807,0.0003241893,0.009937863,0.3659603],"study_design_scores_gemma":[0.1300475,0.3833244,0.4517349,0.0002270637,0.002020572,0.001147577,0.0002030789,0.005101192,0.01147425,0.0003841824,0.01427102,0.0000643587],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926644,0.002384408,0.0002827497,0.0002252021,0.00003204581,0.0004151739,0.001545852,0.00004496365,0.002405173],"genre_scores_gemma":[0.995902,0.0006806935,0.0004725213,0.0001799155,0.00003696265,0.0003175724,0.001552895,0.000003640781,0.0008538843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004358116,"threshold_uncertainty_score":0.01457936,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1276883140255329,"score_gpt":0.4580371891146894,"score_spread":0.3303488750891566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}